Please assess the completion status of the following clinical trial:

Trial Title: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* women 55-80 years of age;~* post-menopausal for \>=5 years;~* ambulatory.~Exclusion Criteria:~* malignant disease diagnosed within the previous 10 years (except basal cell cancer that has been successfully removed);~* breast cancer within the previous 20 years;~* allergy to bisphosphonates;~* previous treatment with an intravenous bisphosphonate at any time;~* previous treatment with an oral bisphosphonate within the last 6 months, \>1 month of treatment within the last year, or \>3 months of treatment within the last 2 years.

- Gender: FEMALE
- Minimum Age: 55 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): oral placebo daily and IV ibandronate 2 mg q 2 mo
- 2 (Type: EXPERIMENTAL): oral ibandronate 2.5 mg daily and IV placebo q 2 mo and q 3 mo
- 3 (Type: EXPERIMENTAL): oral placebo daily and IV ibandronate 3 mg q 3 mo

Based on this trial design, predict the completion outcome and termination type (if applicable).